BBLG Q3 2022 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-28.23

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$395,279

Free Cash Flow

-$395,279

Stock-Based Comp.

$32,534

Balance Sheet

Total Assets

$5M

Total Liabilities

$799,475

Stockholders' Equity

$4M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$1M	-$229,789	-430.5%
Net Income	-$1M	-$509,302	-139.3%